Christopher S. Lathan
Harvard University
90 Papers
249 Citations
Christopher S. Lathan is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 28, co-authored 70 publications. Previous affiliations of Christopher S. Lathan include University of Texas Southwestern Medical Center & Brigham and Women's Hospital.
Chat about Author
Papers
Religiousness and Spiritual Support Among Advanced Cancer Patients and Associations With End-of-Life Treatment Preferences and Quality of Life
Tracy A. Balboni,Lauren C. Vanderwerker,Susan D. Block,M. Elizabeth Paulk,Christopher S. Lathan,John R. Peteet,Holly G. Prigerson +6 more
TL;DR: Many advanced cancer patients' spiritual needs are not supported by religious communities or the medical system, and spiritual support is associated with better QOL.
Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline.
Timothy D. Gilligan,Nessa Coyle,Richard M. Frankel,Donna L. Berry,Kari Bohlke,Ronald M. Epstein,Esme Finlay,Vicki A. Jackson,Christopher S. Lathan,Charles L. Loprinzi,Lynne H. Nguyen,Carole Seigel,Walter F. Baile +12 more
TL;DR: Advice is provided regarding core communication skills and tasks that apply across the continuum of cancer care, such as discussion of goals of care and prognosis, treatment selection, end-of-life care, facilitating family involvement in care, and clinician training in communication skills.
474
Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma
Daniel E. Bauer,Chelsey M. Mitchell,Kelly Strait,Christopher S. Lathan,Edward B. Stelow,Sonja Lüer,Somala Muhammed,Andrew G. Evans,Lynette M. Sholl,Juan Rosai,Eugenia Giraldi,Richard Oakley,Carlos Rodriguez-Galindo,Wendy B. London,Stephen E. Sallan,James E. Bradner,Christopher A. French +16 more
TL;DR: NMC portends a poor prognosis among all squamous cell neoplasms and seems to be frequently unrecognized; the finding that conventional chemotherapy has been inadequate indicates a pressing need for the development of targeted therapeutics.
365
Association of Financial Strain With Symptom Burden and Quality of Life for Patients With Lung or Colorectal Cancer
Christopher S. Lathan,Angel M. Cronin,Reginald D. Tucker-Seeley,S. Yousuf Zafar,John Z. Ayanian,Deborah Schrag +5 more
TL;DR: Patients with cancer and limited financial reserves are more likely to have higher symptom burden and decreased QOL, and Assessment of financial reserves may help identify patients who need intensive support.
Support of cancer patients' spiritual needs and associations with medical care costs at the end of life
Tracy A. Balboni,Michael J. Balboni,M. Elizabeth Paulk,Andrea Phelps,Alexi A. Wright,John R. Peteet,Susan D. Block,Christopher S. Lathan,Tyler J. VanderWeele,Holly G. Prigerson +9 more
TL;DR: Although spiritual care is associated with less aggressive medical care at the end of life (EOL), it remains infrequent and it is unclear if the omission of spiritual care impacts EOL costs.
320